Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Oxonica PLC
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Keystone Nano thinks its expertise in nanotechnology can be leveraged to achieve two valuable commercial goals: improving drug delivery and enhancing medical imaging. The company's Molecular Dots are particles that are just 20-30 nanometers wide and resist clumping. As such, they appear to be able to move through the body without disturbing the immune system.